Practice Points in Breast Cancer Management

Dear Dr. Renukaprasad A R, What makes ribociclib an effective and safe drug for managing advanced breast cancer (aBC)? Endocrine therapy (ET) was a commonly recommended treatment for hormone receptor-positive aBC patients. However, studies have reported that ET alone is ineffective in patients as it was found to cause disease progression and endocrine resistance. In such situations, ribociclib is established as a better option. To get more insights, Novartis has organized the Asia-Pacific Breast Cancer Summit on 27th August 2022 at 05:00 PM IST. Our renowned international oncology experts will discuss ribocliclib's effectiveness in breast cancer management with real-world evidence in this session. Session highlights: Redefining the Standard of Care for Postmenopausal HR+/HER2-aBC A Landmark Therapeutic Milestone for Premenopausal HR+/HER2-aBC Patients Getting Real with Ribociclib: Bridging the RCT and RWE Universe with Evidence Across - 8000 Patients Expert review on aBC Click to Know More   Save Your Seat! India's Largest Online Community of Verified Doctors Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*